Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of February 23, 2025 • 7:00 AM ET

Date/Time Source News Release
02/14/2025 07:30 AM EST GlobeNewswire CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025
02/11/2025 07:30 AM EST GlobeNewswire Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU
01/28/2025 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference
01/08/2025 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025
01/06/2025 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/09/2024 07:00 AM EST GlobeNewswire Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
12/03/2024 07:00 AM EST GlobeNewswire FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
11/21/2024 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
11/12/2024 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
11/07/2024 07:00 AM EST GlobeNewswire Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
Page

Additional News

As of February 23, 2025 • 7:00 AM ET

Date/Time Source News Release
02/14/2025 09:08 AM EST SeekingAlpha Corbus Pharmaceuticals falls after trial data for lead asset
01/09/2025 01:32 AM EST Stock Traders Daily (CRBP) Investment Analysis
12/02/2024 01:34 PM EST SeekingAlpha Corbus, Viking initiated at overweight by Piper Sandler
12/02/2024 05:15 AM EST KlickAnalytics Overweight Recommendation Issued On CRBP By Piper Sandler
11/11/2024 04:12 AM EST SeekingAlpha Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies
11/10/2024 04:39 AM EST US Earnings Reports Expected earnings - Corbus Pharmaceuticals Holdings Inc.
05/13/2024 01:24 PM EDT SeekingAlpha Corbus Pharmaceuticals a new outperform at RBC on cancer, obesity assets
05/13/2024 06:15 AM EDT KlickAnalytics Outperform Recommendation Issued On CRBP By RBC Capital
05/08/2024 05:35 AM EDT US Earnings Reports Expected earnings - Corbus Pharmaceuticals Holdings Inc.
05/07/2024 01:13 PM EDT SeekingAlpha Corbus Pharmaceuticals EPS of -$0.83 beats by $0.26
Page